跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 51 条关于
“ICF004”
全部
51
临床试验
25
药物
21
机构
0
资讯
5
6个月前
CF PharmTech Receives NMPA Acceptance for First-in-Class Inhaled Pulmonary Fibrosis Treatment ICF004
去年
InflaRx Advances Pipeline with Vilobelimab and INF904, Anticipates Key Milestones in 2025
10个月前
InflaRx Stock Surges 67.5% Ahead of Critical Phase 2a Trial Results for INF904
10个月前
InflaRx to Report Phase 2a Results for Oral C5aR Inhibitor INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
10个月前
InflaRx's Oral C5aR Inhibitor INF904 Shows Biologic-Like Efficacy in Phase 2a Trials for Hidradenitis Suppurativa and Chronic Spontaneous Urticaria